Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis.
Del Carpio LP, Algarra MA, Sabaté-Llobera A, Rodriguez-Vida A, Rossi-Seoane S, Ruiz S, Leiva D, Ramos E, Lladò L, Lorenzo D, Gutierrez C, Cortes-Romera M, Caminal JM, Piulats JM. Del Carpio LP, et al. Among authors: algarra ma. Cancer Med. 2023 Jul;12(13):14062-14071. doi: 10.1002/cam4.6058. Epub 2023 May 21. Cancer Med. 2023. PMID: 37211960 Free PMC article.
Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy.
Herrero-Vicent C, Guerrero A, Gavilá J, Gozalbo F, Hernández A, Sandiego S, Algarra MA, Calatrava A, Guillem-Porta V, Ruiz-Simón A. Herrero-Vicent C, et al. Among authors: algarra ma. Ecancermedicalscience. 2017 Aug 15;11:759. doi: 10.3332/ecancer.2017.759. eCollection 2017. Ecancermedicalscience. 2017. PMID: 28900472 Free PMC article.
Advanced systemic amyloidosis secondary to metastatic renal cell carcinoma.
Algarra MA, Fita MJJ, Sandiego S, Aguilar HA, Álvarez P, Quispe M, Salvador A, Egido A, Lavernia J, Machado I, Rubio-Briones J, Climent MÁ. Algarra MA, et al. Ecancermedicalscience. 2020 Dec 15;14:1156. doi: 10.3332/ecancer.2020.1156. eCollection 2020. Ecancermedicalscience. 2020. PMID: 33574901 Free PMC article.
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer.
Afferi L, Lonati C, Montorsi F, Briganti A, Necchi A, Mari A, Minervini A, Tellini R, Campi R, Schulz GB, Black PC, di Trapani E, de Cobelli O, Karnes RJ, Ahmed M, Mir MC, Algarra MA, Rink M, Zamboni S, Mondini F, Simeone C, Antonelli A, Tafuri A, Krajewski W, Małkiewicz B, Xylinas E, Soria F, Sanchez Salas R, Arora A, Cathelineau X, Hendricksen K, Ammiwala M, Borghesi M, Chierigo F, Teoh JY, Mattei A, Albisinni S, Roghmann F, Roumiguié M, Bajeot AS, Maier E, Aziz A, Hurle R, Contieri R, Pradere B, Carando R, Poyet C, Alvarez-Maestro M, D'Andrea D, Shariat SF, Moschini M; European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group. Afferi L, et al. Among authors: algarra ma. Eur Urol Oncol. 2022 Dec;5(6):722-725. doi: 10.1016/j.euo.2022.04.001. Epub 2022 Jun 15. Eur Urol Oncol. 2022. PMID: 35715319
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer.
Afferi L, Lonati C, Montorsi F, Briganti A, Necchi A, Mari A, Minervini A, Campi R, di Trapani E, de Cobelli O, Karnes RJ, Ahmed M, Mir MC, Algarra MA, Rink M, Zamboni S, Simeone C, Krajewski W, Xylinas E, Soria F, Hendricksen K, Einerhand S, Mattei A, Carando R, Roumiguié M, Bajeot AS, Black PC, Shariat SF, Moschini M; European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. Afferi L, et al. Among authors: algarra ma. World J Urol. 2022 Jun;40(6):1489-1496. doi: 10.1007/s00345-022-03948-x. Epub 2022 Feb 10. World J Urol. 2022. PMID: 35142865
Dusky erythema secondary to anti-MEK therapy.
Bancalari B, Algarra MA, Llombart B, Nagore E, Soriano V, Sanmartín O, Requena C. Bancalari B, et al. Among authors: algarra ma. Melanoma Res. 2019 Aug;29(4):449-451. doi: 10.1097/CMR.0000000000000602. Melanoma Res. 2019. PMID: 31246729 No abstract available.